You're contacting media contact of this press release

Title: MEnera The New OTC Biologic For Transforming Womens Reproductive Health

Tampa, Florida, United States, 19th Jun 2025 – Women seeking science-backed solutions for hormonal balance and fertility support have a new reason to be hopeful. Medicinal Technologies, a cutting-edge U.S.-based biopharmaceutical firm, has announced the late 2025 launch of MEnera—a revolutionary over-the-counter biologic designed to relieve menstrual irregularities, menopausal symptoms, PCOS , and even infertility.MEnera is the result of years of research into  small cell biologics, guided by the groundbreaking Tejeda Equation, which uncovered the hidden molecular causes of Endometriosis. Accordingly to lead medical scientist Dr  Sheryene Tejeda working at the root level of endocrine function, MEnera assists in restoring  hormonal rhythms without the use of synthetics.“This is a personal health revolution,” said a Dr. Tejeda. “MEnera delivers real biological change that women can trust—because it’s built on clinical science, not hype.”Women experiencing:Hormonal imbalanceLow energy Low libidoLow egg qualityMenopausal symptomsIrregular periodsFertility challenges…can benefit from MEnera’s targeted action. Each bottle is priced affordably and is backed by Medicinal Technologies’ commitment to scientific rigor and safety. MEnera will be available in local drug stores.What Makes MEnera Unique?FDA-registered and regulatedActs at endocrine and cellular levelsSuitable for women with PCOS or preparing for conceptionResearch-based, not trend-based.MEnera also represents a new chapter for Medicinal Technologies as it expands into personalized wellness and over-the-counter therapeutics, addressing unmet needs in global health with empathy and expertise.About Medicinal TechnologiesFrom opthamology to women’s health, Medicinal Technologies lev...

This press release is issued by King Newswire